LETTER
FMS of Tetrafibricin Fragment Isomers
671
(4) (a) Luo, Z. Y.; Zhang, Q. S.; Oderaotoshi, Y.; Curran, D. P.
Science 2001, 291, 1766. (b) Yang, F.; Newsome, J. J.;
Curran, D. P. J. Am. Chem. Soc. 2006, 128, 14200.
(c) Jung, W.-H.; Guyenne, S.; Riesco-Fagundo, C.;
Mancuso, J.; Nakamura, S.; Curran, D. P. Angew. Chem. Int.
Ed. 2008, 47, 1130. (d) Curran, D. P.; Sui, B. J. Am. Chem.
Soc. 2009, 131, 5411. (e) Zhang, Q. S.; Curran, D. P. Chem.
Eur. J. 2005, 11, 4866.
(5) Blakemore, P. R. J. Chem. Soc., Perkin Trans. 1 2002, 2563.
(6) Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.;
Hansen, K. B.; Gould, A. E.; Furrow, M. E.; Jacobson, E. N.
J. Am. Chem. Soc. 2002, 124, 1307.
learned from comparison of the spectra which resonances
are diagnostic for differentiating the isomers.
Supporting Information for this article is available online at
contains full experimental details and compound characterizations
along with copies of NMR spectra of quasiisomers 21 and diaste-
reomers 2 and a comparison table of 13C NMR chemical shifts of 2.
Acknowledgment
(7) Gaunt, M. J.; Hook, D. F.; Tanner, H. R.; Ley, S. V. Org.
Lett. 2003, 5, 4815.
(8) Zhang, W.; Luo, Z.; Chen, C. H.-T.; Curran, D. P. J. Am.
Chem. Soc. 2002, 124, 10443.
We thank the National Institutes of Health, National Institute of
General Medical Sciences, for funding this work.
(9) Smith, A. B. III.; Pitram, S. M.; Fuertes, M. J. Org. Lett.
2003, 5, 2751.
(10) Mitsunobu, O. Synthesis 1981, 1.
References and Notes
(1) (a) Kamiyama, T.; Itezono, Y.; Umino, T.; Satoh, T.;
Nakayama, N.; Yokose, K. J. Antibiot. 1993, 46, 1047.
(b) Kamiyama, T.; Umino, T.; Fujisaki, N.; Fujimori, K.;
Satoh, T.; Yamashita, Y.; Ohshima, S.; Watanabe, J.;
Yokose, K. J. Antibiot. 1993, 46, 1039.
(11) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
(12) Blakemore, P. R.; Browder, C. C.; Hong, J.; Lincoln, C. M.;
Nagornyy, P. A.; Robarge, L. A.; Wardrop, D. J.; White,
J. D. J. Org. Chem. 2005, 70, 5449.
(13) Jung, W.-H.; Harrison, C.; Shin, Y.; Fournier, J.-H.;
Balachandran, R.; Raccor, B. S.; Sikorski, R. P.; Vogt, A.;
Curran, D. P.; Day, B. W. J. Med. Chem. 2007, 50, 2951.
(14) Paquette, L. A.; Chang, S. Org. Lett. 2005, 7, 3111.
(15) (a) The column is available from Fluorous Technologies,
Inc. (b) D.P.C. owns an equity interest in this company.
(16) Oishi, T.; Kanemoto, M.; Swasono, R.; Matsumori, N.;
Murata, M. Org. Lett. 2008, 10, 5203.
(2) Kobayashi, Y.; Czechtizky, W.; Kishi, Y. Org. Lett. 2003, 5,
93.
(3) (a) BouzBouz, S.; Cossy, J. Org. Lett. 2004, 6, 3469.
(b) Lira, R.; Roush, W. R. Org. Lett. 2007, 9, 533.
(c) Gudipati, V. PhD Thesis; University of Pittsburgh: USA,
04212008-115104/. (d) Gudipati, V.; Bajpai, R.; Curran,
D. P. Collect. Czech. Chem. Commun. 2009, 74, 774.
Synlett 2010, No. 4, 667–671 © Thieme Stuttgart · New York